290 related articles for article (PubMed ID: 32646482)
1. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial.
Asimakopoulos G; Pergialiotis V; Anastasiou E; Antsaklis P; Theodora M; Vogiatzi E; Kallergi A; Sindos M; Loutradis D; Daskalakis G
Trials; 2020 Jul; 21(1):633. PubMed ID: 32646482
[TBL] [Abstract][Full Text] [Related]
2. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.
Matarrelli B; Vitacolonna E; D'Angelo M; Pavone G; Mattei PA; Liberati M; Celentano C
J Matern Fetal Neonatal Med; 2013 Jul; 26(10):967-72. PubMed ID: 23327487
[TBL] [Abstract][Full Text] [Related]
3. Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
D'Anna R; Di Benedetto A; Scilipoti A; Santamaria A; Interdonato ML; Petrella E; Neri I; Pintaudi B; Corrado F; Facchinetti F
Obstet Gynecol; 2015 Aug; 126(2):310-315. PubMed ID: 26241420
[TBL] [Abstract][Full Text] [Related]
4. The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial.
Esmaeilzadeh S; Ghadimi R; Mashayekh-Amiri S; Delavar MA; Basirat Z
Minerva Obstet Gynecol; 2023 Aug; 75(4):357-364. PubMed ID: 35686634
[TBL] [Abstract][Full Text] [Related]
5. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial.
Celentano C; Matarrelli B; Pavone G; Vitacolonna E; Mattei PA; Berghella V; Liberati M
J Matern Fetal Neonatal Med; 2020 Mar; 33(5):743-751. PubMed ID: 30558466
[No Abstract] [Full Text] [Related]
6. Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial.
Ibrahim I; Abdullahi H; Fagier Y; Ortashi O; Terrangera A; Okunoye G
BMJ Open; 2022 Jan; 12(1):e055314. PubMed ID: 34983771
[TBL] [Abstract][Full Text] [Related]
7. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial.
Fraticelli F; Celentano C; Zecca IA; Di Vieste G; Pintaudi B; Liberati M; Franzago M; Di Nicola M; Vitacolonna E
Acta Diabetol; 2018 Aug; 55(8):805-812. PubMed ID: 29774465
[TBL] [Abstract][Full Text] [Related]
8. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.
Farren M; Daly N; McKeating A; Kinsley B; Turner MJ; Daly S
Diabetes Care; 2017 Jun; 40(6):759-763. PubMed ID: 28325784
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and acceptability of
Amaefule CE; Drymoussi Z; Dodds J; Sweeney L; Pizzo E; Daru J; Robson J; Poston L; Khalil A; Myers J; Harden A; Hitman GA; Khan K; Zamora J; Huda MSB; Thangaratinam S
BMJ Open; 2018 Sep; 8(9):e022831. PubMed ID: 30249632
[TBL] [Abstract][Full Text] [Related]
10. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Croze ML; Soulage CO
Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
[TBL] [Abstract][Full Text] [Related]
11. Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study.
Amaefule CE; Drymoussi Z; Gonzalez Carreras FJ; Pardo Llorente MDC; Lanz D; Dodds J; Sweeney L; Pizzo E; Thomas A; Heighway J; Daru J; Sobhy S; Poston L; Khalil A; Myers J; Harden A; Hitman G; Khan KS; Zamora J; Pérez T; Huda MSB; Thangaratinam S
BMJ Open; 2022 Mar; 12(3):e050110. PubMed ID: 35277398
[TBL] [Abstract][Full Text] [Related]
12. Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results.
Dell'Edera D; Sarlo F; Allegretti A; Epifania AA; Simone F; Lupo MG; Benedetto M; D'Apice MR; Capalbo A
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3305-3311. PubMed ID: 28770950
[TBL] [Abstract][Full Text] [Related]
13. Higher early pregnancy plasma myo-inositol associates with increased postprandial glycaemia later in pregnancy: Secondary analyses of the NiPPeR randomized controlled trial.
Chan SY; Zhang H; Wong JT; Chang HF; Chen LW; Barton SJ; Nield H; El-Heis S; Kenealy T; Lavalle L; Ramos-Nieves JM; Godin JP; Silva-Zolezzi I; Cutfield WS; Godfrey KM;
Diabetes Obes Metab; 2024 May; 26(5):1658-1669. PubMed ID: 38312016
[TBL] [Abstract][Full Text] [Related]
14. The effects of myo-inositol and probiotic supplementation in a high-fat-fed preclinical model of glucose intolerance in pregnancy.
Plows JF; Ramos Nieves JM; Budin F; Mace K; Reynolds CM; Vickers MH; Silva-Zolezzi I; Baker PN; Stanley JL
Br J Nutr; 2020 Mar; 123(5):516-528. PubMed ID: 31771683
[TBL] [Abstract][Full Text] [Related]
15. Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review.
D'Anna R; Santamaria A; Alibrandi A; Corrado F; DI Benedetto A; Facchinetti F
J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S59-S61. PubMed ID: 31619648
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis.
Factor PA; Corpuz H
J ASEAN Fed Endocr Soc; 2023; 38(2):102-112. PubMed ID: 38045667
[TBL] [Abstract][Full Text] [Related]
17. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.
Santamaria A; Di Benedetto A; Petrella E; Pintaudi B; Corrado F; D'Anna R; Neri I; Facchinetti F
J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3234-7. PubMed ID: 26698911
[TBL] [Abstract][Full Text] [Related]
18. Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus.
Celentano C; Matarrelli B; Mattei PA; Pavone G; Vitacolonna E; Liberati M
Curr Diab Rep; 2016 Mar; 16(3):30. PubMed ID: 26898405
[TBL] [Abstract][Full Text] [Related]
19. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.
Santamaria A; Alibrandi A; Di Benedetto A; Pintaudi B; Corrado F; Facchinetti F; D'Anna R
Am J Obstet Gynecol; 2018 Sep; 219(3):300.e1-300.e6. PubMed ID: 29859136
[TBL] [Abstract][Full Text] [Related]
20. Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.
Vitagliano A; Saccone G; Cosmi E; Visentin S; Dessole F; Ambrosini G; Berghella V
Arch Gynecol Obstet; 2019 Jan; 299(1):55-68. PubMed ID: 30564926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
